Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice

Patients with the renal phosphate–wasting disease X-linked hypophosphatemia (XLH) and Hyp mice, the murine homolog of XLH, are characterized by loss-of-function mutations in phosphate-regulating endopeptidase homolog X-linked (PHEX), leading to excessive secretion of the bone-derived phosphotropic h...

Full description

Bibliographic Details
Main Authors: Achim Buck, Verena M. Prade, Thomas Kunzke, Reinhold G. Erben, Axel Walch
Format: Article
Language:English
Published: American Society for Clinical investigation 2022-10-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.162138
_version_ 1797634366698946560
author Achim Buck
Verena M. Prade
Thomas Kunzke
Reinhold G. Erben
Axel Walch
author_facet Achim Buck
Verena M. Prade
Thomas Kunzke
Reinhold G. Erben
Axel Walch
author_sort Achim Buck
collection DOAJ
description Patients with the renal phosphate–wasting disease X-linked hypophosphatemia (XLH) and Hyp mice, the murine homolog of XLH, are characterized by loss-of-function mutations in phosphate-regulating endopeptidase homolog X-linked (PHEX), leading to excessive secretion of the bone-derived phosphotropic hormone FGF23. The mineralization defect in patients with XLH and Hyp mice is caused by a combination of hypophosphatemia and local accumulation of mineralization-inhibiting molecules in bone. However, the mechanism by which PHEX deficiency regulates bone cell metabolism remains elusive. Here, we used spatial metabolomics by employing matrix-assisted laser desorption/ionization (MALDI) Fourier-transform ion cyclotron resonance mass spectrometry imaging (MSI) of undecalcified bone cryosections to characterize in situ metabolic changes in bones of Hyp mice in a holistic, unbiased manner. We found complex changes in Hyp bone metabolism, including perturbations in pentose phosphate, purine, pyrimidine, and phospholipid metabolism. Importantly, our study identified an upregulation of several biochemical pathways involved in intra- and extracellular production of the mineralization inhibitor pyrophosphate in the bone matrix of Hyp mice. Our data emphasize the utility of MSI–based spatial metabolomics in bone research and provide holistic in situ insights as to how Phex deficiency–induced changes in biochemical pathways in bone cells are linked to impaired bone mineralization.
first_indexed 2024-03-11T12:06:41Z
format Article
id doaj.art-738894d08d474637a6e6f0eeaa6111fe
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:06:41Z
publishDate 2022-10-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-738894d08d474637a6e6f0eeaa6111fe2023-11-07T16:24:43ZengAmerican Society for Clinical investigationJCI Insight2379-37082022-10-01720Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp miceAchim BuckVerena M. PradeThomas KunzkeReinhold G. ErbenAxel WalchPatients with the renal phosphate–wasting disease X-linked hypophosphatemia (XLH) and Hyp mice, the murine homolog of XLH, are characterized by loss-of-function mutations in phosphate-regulating endopeptidase homolog X-linked (PHEX), leading to excessive secretion of the bone-derived phosphotropic hormone FGF23. The mineralization defect in patients with XLH and Hyp mice is caused by a combination of hypophosphatemia and local accumulation of mineralization-inhibiting molecules in bone. However, the mechanism by which PHEX deficiency regulates bone cell metabolism remains elusive. Here, we used spatial metabolomics by employing matrix-assisted laser desorption/ionization (MALDI) Fourier-transform ion cyclotron resonance mass spectrometry imaging (MSI) of undecalcified bone cryosections to characterize in situ metabolic changes in bones of Hyp mice in a holistic, unbiased manner. We found complex changes in Hyp bone metabolism, including perturbations in pentose phosphate, purine, pyrimidine, and phospholipid metabolism. Importantly, our study identified an upregulation of several biochemical pathways involved in intra- and extracellular production of the mineralization inhibitor pyrophosphate in the bone matrix of Hyp mice. Our data emphasize the utility of MSI–based spatial metabolomics in bone research and provide holistic in situ insights as to how Phex deficiency–induced changes in biochemical pathways in bone cells are linked to impaired bone mineralization.https://doi.org/10.1172/jci.insight.162138Bone biology
spellingShingle Achim Buck
Verena M. Prade
Thomas Kunzke
Reinhold G. Erben
Axel Walch
Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice
JCI Insight
Bone biology
title Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice
title_full Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice
title_fullStr Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice
title_full_unstemmed Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice
title_short Spatial metabolomics reveals upregulation of several pyrophosphate-producing pathways in cortical bone of Hyp mice
title_sort spatial metabolomics reveals upregulation of several pyrophosphate producing pathways in cortical bone of hyp mice
topic Bone biology
url https://doi.org/10.1172/jci.insight.162138
work_keys_str_mv AT achimbuck spatialmetabolomicsrevealsupregulationofseveralpyrophosphateproducingpathwaysincorticalboneofhypmice
AT verenamprade spatialmetabolomicsrevealsupregulationofseveralpyrophosphateproducingpathwaysincorticalboneofhypmice
AT thomaskunzke spatialmetabolomicsrevealsupregulationofseveralpyrophosphateproducingpathwaysincorticalboneofhypmice
AT reinholdgerben spatialmetabolomicsrevealsupregulationofseveralpyrophosphateproducingpathwaysincorticalboneofhypmice
AT axelwalch spatialmetabolomicsrevealsupregulationofseveralpyrophosphateproducingpathwaysincorticalboneofhypmice